FC2ブログ

バイオの戯言

ライフサイエンスに関する話題についてコメント(戯言?)を述べていくブログです。

【プレスリリースメモ】 RNAi関係 (2013.3.16)  

<Mesoblast>(Angioblast Systemsを買収)
MESOBLAST COMPLETES A$170M PRIVATE PLACEMENT(2013.3.14)

<Antisense Therapeutics>
Investor Presentation(2013.3.13)
ANP to present at ROTH Capital Partners 25th Annual Growth Stock Conference(2013.3.14)

<Arrowhead Research>
Arrowhead RNAi Candidate ARC-520 Induces Greater than 90% Reduction in Circulating HBV DNA in Chimpanzee with Chronic Hepatitis B(2013.3.14)

<Benitec>
Hepatitis C clinical trial progress update(2013.3.8)

<Bio-Path Holdings>
Bio-Path Holdings Begins Enrollment in Fifth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemias(2013.3.7)

<Ceregene>
Ceregene and Alzheimer's Disease Cooperative Study Group Complete Enrollment of CERE-110 Phase 2 Trial(2013.3.13)

<CytRx Corporation>
CytRx Reports 2012 Financial Results(2013.3.11)
CytRx to Present at the 25th Annual ROTH Conference(2013.3.12)

<Exiqon A/S>
Exiqon A/S - EXIQON CALLS FOR AN ORDINARY GENERAL MEETING ON 4 APRIL 2013(2013.3.12)

<Galena Biopharma>
Galena Biopharma to Present at the 25th Annual ROTH Conference(2013.3.11)
Galena Biopharma Reports Year-End 2012 Financial Results(2013.3.12)
Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM)(2013.3.14)

<Idera Pharmaceuticals>
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial Results and Provides Update on Autoimmune Disease Program(2013.3.12)

<Isis Pharmaceuticals>
Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx(2013.3.13)
Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting(2013.3.14)
Isis Pharmaceuticals to Present at the 25th Annual ROTH Conference(2013.3.15)

<Pharmaxis>
Pharmaxis Appoints Gary Phillips as New Chief Executive Officer(2013.3.12)

<Rosetta Genomics>
Rosetta Genomics to Present at the 25th Annual Roth Conference(2013.3.12)

<RXi Pharmaceuticals>
RXi Pharmaceuticals to Present at the 25th Annual ROTH Conference(2013.3.12)

<アンジェスMG>
第三者割当による新株式発行の払込完了に関するお知らせ(2013.3.11)

<第一三共>
独自技術を用いたデュシェンヌ型筋ジストロフィー核酸医薬の開発について(2013.2.14)


スポンサーサイト
[ 2013/03/17 00:40 ] プレスリリース | TB(0) | CM(0)
コメントの投稿













管理者にだけ表示を許可する
最新ニュース
お気に入り
カレンダー(月別)
07 ≪│2018/08│≫ 09
- - - 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 -
特選品
特許関係の書籍-3
特許関係の書籍-2
特許関係の書籍-1
情報関係の書籍
月別アーカイブ
プロフィール

のぐひで

Author:のぐひで
FC2ブログへようこそ!